Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prometic Plasma Resources was a Prometic/Liminal BioSciences-owned plasma collection business focused on sourcing human plasma for the manufacture of plasma-derived therapeutics. It operated collection centers in Winnipeg, Manitoba and Amherst, New York, supporting the plasma supply chain rather than developing a broad internal drug pipeline. In 2021, Liminal BioSciences divested Prometic Plasma Resources and Prometic Plasma Resources (USA) to Kedrion, and in early 2022 the Winnipeg donation center was subsequently acquired by Grifols. The Prometic Plasma Resources brand has since been phased out, with the Winnipeg operation rebranded under Grifols Plasma Canada. The entity is therefore best understood as a historical plasma collection company rather than a currently independent operating biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prometic Plasma Resources.